POPULATION PHARMACOKINETICS OF PROCAINAMIDE FROM ROUTINE CLINICAL-DATA

[1] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J]. NEPHRON, 1976, 16 (01) : 31 - 41

[2] DUDUBOIS, 1916, ARCH INTERN MED, V17, P863

[3] DUSOUICH P, 1976, EUR J CLIN PHARMACOL, V9, P433

[4] DUTCHER JS, 1977, CLIN PHARMACOL THER, V22, P447

[5] GALEAZZI RL, 1976, CLIN PHARMACOL THER, V19, P55

[6] GIARDINA EGV, 1976, CLIN PHARMACOL THER, V19, P339

[7] GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P321

[8] KABRA PM, 1981, THER DRUG MONIT, V3, P91

[9] PROCAINAMIDE DOSAGE SCHEDULES, PLASMA CONCENTRATIONS, AND CLINICAL EFFECTS [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (09) : 1454 - +

[10] PHARMACOKINETIC APPROACH TO INTRAVENOUS PROCAINAMIDE THERAPY [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (04) : 303 - 308

[1] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J]. NEPHRON, 1976, 16 (01) : 31 - 41

[2] DUDUBOIS, 1916, ARCH INTERN MED, V17, P863

[3] DUSOUICH P, 1976, EUR J CLIN PHARMACOL, V9, P433

[4] DUTCHER JS, 1977, CLIN PHARMACOL THER, V22, P447

[5] GALEAZZI RL, 1976, CLIN PHARMACOL THER, V19, P55

[6] GIARDINA EGV, 1976, CLIN PHARMACOL THER, V19, P339

[7] GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P321

[8] KABRA PM, 1981, THER DRUG MONIT, V3, P91

[9] PROCAINAMIDE DOSAGE SCHEDULES, PLASMA CONCENTRATIONS, AND CLINICAL EFFECTS [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (09) : 1454 - +

[10] PHARMACOKINETIC APPROACH TO INTRAVENOUS PROCAINAMIDE THERAPY [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (04) : 303 - 308